CSBR — Champions Oncology Share News
0.000.00%
Last trade - 00:00- $66.67m
- $63.16m
- $59.43m
Brief: Champions Oncology Q1 Adjusted EPS USD 0.05
Champions Oncology Q4 revenue rises; margin improves driven by cost discipline
Brief: Champions Oncology Q4 Adjusted EPS USD 0.01
Champions Oncology Q3 revenue dips 3%
Brief: Champions Oncology Q3 Adjusted EPS USD 0.04
Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improves
Brief: Champions Oncology Q2 Adjusted EPS USD 0.06
Brief: Champions Oncology Q1 Adjusted EPS USD 0.02
Champions Oncology Inc reports results for the quarter ended April 30 - Earnings Summary
Champions Oncology Q4 revenue beats analyst expectations
Champions Oncology Inc expected to post a loss of 20 cents a share - Earnings Preview
RCS - Champions Oncology - Champions Launches Radiopharmaceutical Services
Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview
RCS - Champions Oncology - Champions Oncology Enhances Clinical Bioanalytical
Champions Oncology Inc reports results for the quarter ended October 31 - Earnings Summary
Champions Oncology Inc expected to post earnings of 1 cent a share - Earnings Preview
Champions Oncology Inc expected to post earnings of 1 cent a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary
Champions Oncology Inc expected to post a loss of 10 cents a share - Earnings Preview